IL90750A0 - Ribonucleotide reductase inhibitors and antiviral combinations comprising them - Google Patents

Ribonucleotide reductase inhibitors and antiviral combinations comprising them

Info

Publication number
IL90750A0
IL90750A0 IL90750A IL9075089A IL90750A0 IL 90750 A0 IL90750 A0 IL 90750A0 IL 90750 A IL90750 A IL 90750A IL 9075089 A IL9075089 A IL 9075089A IL 90750 A0 IL90750 A0 IL 90750A0
Authority
IL
Israel
Prior art keywords
ribonucleotide reductase
reductase inhibitors
antiviral combinations
antiviral
combinations
Prior art date
Application number
IL90750A
Other languages
English (en)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IL90750A0 publication Critical patent/IL90750A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL90750A 1988-06-27 1989-06-26 Ribonucleotide reductase inhibitors and antiviral combinations comprising them IL90750A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888815241A GB8815241D0 (en) 1988-06-27 1988-06-27 Antiviral combinations & compounds therefor

Publications (1)

Publication Number Publication Date
IL90750A0 true IL90750A0 (en) 1990-01-18

Family

ID=10639423

Family Applications (1)

Application Number Title Priority Date Filing Date
IL90750A IL90750A0 (en) 1988-06-27 1989-06-26 Ribonucleotide reductase inhibitors and antiviral combinations comprising them

Country Status (19)

Country Link
US (3) US5175165A (de)
EP (1) EP0349243B1 (de)
JP (1) JPH0245423A (de)
KR (1) KR910000149A (de)
AT (1) ATE74276T1 (de)
AU (1) AU626304B2 (de)
DE (1) DE68901111D1 (de)
DK (1) DK315889A (de)
ES (1) ES2031357T3 (de)
FI (1) FI893112A7 (de)
GB (1) GB8815241D0 (de)
GR (1) GR3005067T3 (de)
HU (1) HU206264B (de)
IE (1) IE64496B1 (de)
IL (1) IL90750A0 (de)
MY (1) MY106304A (de)
NZ (1) NZ229711A (de)
PT (1) PT90972B (de)
ZA (1) ZA894835B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164395A (en) * 1988-06-27 1992-11-17 Burroughs Wellcome Co. Antiviral acetyl pyridine derivative or said acetyl pyridine derivative in combination with acyclovir
GB8815241D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Antiviral combinations & compounds therefor
US5674849A (en) * 1990-10-24 1997-10-07 Allelix Biopharmaceuticals Inc. Anti-viral compositions
CA2033447C (en) * 1990-12-31 1999-08-31 Robert Deziel Synergistic combination for treating herpes infections
CA2033448C (en) * 1990-12-31 1996-11-26 Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee Antiherpes compositions and method of use
US5879700A (en) * 1991-10-15 1999-03-09 Hostetler; Karl Y. Nucleoside analogue phosphates for topical use
US5580571A (en) * 1991-10-15 1996-12-03 Hostetler; Karl Y. Nucleoside analogues
US5654286A (en) * 1993-05-12 1997-08-05 Hostetler; Karl Y. Nucleotides for topical treatment of psoriasis, and methods for using same
AU701574B2 (en) * 1993-05-12 1999-02-04 Karl Y. Hostetler Acyclovir derivatives for topical use
US6015573A (en) * 1993-05-12 2000-01-18 Hostetler; Karl Y. Nucleoside phosphate therapy for viral infection
GB9315755D0 (en) * 1993-07-30 1993-09-15 Wellcome Found Stabilized formulation
WO1996001638A1 (en) * 1994-07-11 1996-01-25 Hoechst Marion Roussel, Inc. Method of treating a neoplastic disease state by conjunctive therapy with 2'-fluoromethylidene derivatives and radiation or chemotherapy
US5693791A (en) * 1995-04-11 1997-12-02 Truett; William L. Antibiotics and process for preparation
US6475491B1 (en) 1995-06-07 2002-11-05 Trimeris, Inc. Treatment of HIV and other viral infections using combinatorial therapy
US20030212051A1 (en) * 2001-04-06 2003-11-13 Polli James E Bile acid containing prodrugs with enhanced bioavailabilty
US20080132527A1 (en) 2004-05-19 2008-06-05 Emisphere Technologies, Inc. Compositions For Delivering Acyclovir
JP4972062B2 (ja) * 2008-03-17 2012-07-11 メディヴィル・アクチエボラーグ 抗ウイルス製剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1523865A (en) * 1974-09-02 1978-09-06 Wellcome Found Purine compunds and salts thereof
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
US4777166A (en) * 1982-03-30 1988-10-11 The United States Of America As Represented By The Secretary Of The Army 2-acetylpyridine thiosemicarbazone compositions as anitviral agents
US4609662A (en) * 1982-10-14 1986-09-02 Burroughs Wellcome Co. Method for using purine derivatives
GB8320308D0 (en) * 1983-07-28 1983-09-01 Wellcome Found Antiviral combinations
US4606917A (en) * 1984-10-03 1986-08-19 Syntex (U.S.A) Inc. Synergistic antiviral composition
US4751221A (en) * 1985-10-18 1988-06-14 Sloan-Kettering Institute For Cancer Research 2-fluoro-arabinofuranosyl purine nucleosides
US4829055A (en) * 1987-01-23 1989-05-09 Naficy Sadeque S Method of treatment for herpes infections of external tissues
GB8815241D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Antiviral combinations & compounds therefor
GB8823319D0 (en) * 1988-10-05 1988-11-09 Nycomed As Chemical compounds
GB8823320D0 (en) * 1988-10-05 1988-11-09 Nycomed As Chemical compounds

Also Published As

Publication number Publication date
EP0349243A3 (en) 1990-07-11
ATE74276T1 (de) 1992-04-15
HU206264B (en) 1992-10-28
IE892060L (en) 1989-12-27
DK315889D0 (da) 1989-06-26
DE68901111D1 (de) 1992-05-07
ES2031357T3 (es) 1992-12-01
AU3702689A (en) 1990-02-01
EP0349243A2 (de) 1990-01-03
US5021437A (en) 1991-06-04
FI893112A0 (fi) 1989-06-26
MY106304A (en) 1995-04-29
EP0349243B1 (de) 1992-04-01
DK315889A (da) 1989-12-28
FI893112L (fi) 1989-12-28
GR3005067T3 (de) 1993-05-24
ZA894835B (en) 1991-02-27
GB8815241D0 (en) 1988-08-03
NZ229711A (en) 1992-08-26
US5175165A (en) 1992-12-29
PT90972B (pt) 1995-01-31
JPH0245423A (ja) 1990-02-15
IE64496B1 (en) 1995-08-09
KR910000149A (ko) 1991-01-29
PT90972A (pt) 1989-12-29
US5393883A (en) 1995-02-28
AU626304B2 (en) 1992-07-30
FI893112A7 (fi) 1989-12-28
HUT52379A (en) 1990-07-28

Similar Documents

Publication Publication Date Title
GR3005067T3 (de)
ES2191292T3 (es) Compuestos antivirales poliaromaticos.
EP0810209A3 (de) Hydroxyethylaminosulfonamide verwendbar als Inhibitoren retroviraler Proteasen
AU5736494A (en) Cyclic sulfone containing retroviral protease inhibitors
EP0528858A4 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
MX9305766A (es) Procedimiento para la preparacion de derivados de taxano y productosobtenidos por medio del mismo.
CA2140928A1 (en) Sulfonylalkanoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
AU2489197A (en) Carbocyclic intermediates and process of manufacture thereof
CA2129132A1 (en) Antiviral agent
GR3020451T3 (en) Retroviral protease inhibitors
NZ240230A (en) Mercaptoacetylamide derivatives; preparation, use and pharmaceutical compositions thereof
IL79700A0 (en) Antiviral compositions containing 2',3'-dideoxyinosine,2',3'-dideoxy-guanosine or 2',3'-dideoxyadenosine or phosphates thereof
GR3034894T3 (en) Retroviral protease inhibitors
WO1993017651A3 (de) Antivirale nucleosidanaloge, ihre herstellung und ihre verwendung
HUT47855A (en) Process for production of medical compositions containing two-faded dns and applicable in loco
GB2326412A (en) Naphthyridine derivatives and their analogues inhibiting cytomegalovirus
AU3595589A (en) Hirudin derivatives with delayed action
AU9009191A (en) Synergistic combination for treating herpes infections
AU1099488A (en) Wood treatment composition and process
AU2462284A (en) Purines
ES2102772T3 (es) Compuesto citotoxico y antiviral.
WO2001025239A3 (en) Oxazinoquinolones useful for the treatment of viral infections
NZ241121A (en) Antiviral composition for treating herpes comprising a nucleoside analog & a ribonucleotide reductase inhibiting peptide derivative
NO960927L (no) Fremgangsmåte ved fremstilling av 9-(2-hydroksy)-etoksymetylguanin
FI954048A7 (fi) Herpes-virus-rikbonukleotidireduktaasin estäjät

Legal Events

Date Code Title Description
RH Patent void